Nature Communications, 2025
Modifiable risk factors and plasma proteomics in relation to complications of type 2 diabetes

Li R., Tian S., Liu J. et al.

Scientific Reports, 2025
Deciphering genetic causality between plasma BDNF and 91 circulating inflammatory proteins through bidirectional mendelian randomization

Sun Y., Shi X., Ohm M. et al.

Neuro-Oncology, 2025
A multi-institutional phase 1 clinical trial exploring upfront multimodal standard of care and combined immunotherapies for newly diagnosed glioblastoma

Wen P., Manzanera A., Duault C. et al.

Nature Communications, 2025
Associations of 2923 plasma proteins with incident inflammatory bowel disease in a prospective cohort study and genetic analysis

Zhang X., Zhao H., Wan M. et al.

BMC Anesthesiology, 2025
Dexamethasone vs. placebo modulation of the perioperative blood immune proteome in patients undergoing total knee arthroplasty

Mølgaard A., Gasbjerg K., Mathiesen O. et al.

JHLT Open, 2025
Allogeneic mesenchymal stromal cell therapy on primary graft dysfunction after lung transplantation

Qayyum A., Lund T., Jensen P. et al.

Journal of Affective Disorders, 2025
Association of childhood emotional neglect, circulating protein biomarkers, with gastrointestinal disorders among UK biobank participants

Qiao C., Qin X., Song Y. et al.

The Journal of Headache and Pain, 2025
Uncovering drug targets for cluster headache through proteome-wide Mendelian randomization analysis

Xiong Z., Guo Z., Zhao L. et al.

Molecular Psychiatry, 2025
Large-scale plasma proteomics uncovers novel targets linking ambient air pollution and depression

Pan C., Qi X., Yang X. et al.

Scientific Reports, 2025
Multi-omic biomarkers associated with multiple sclerosis: from Mendelian randomization to drug prediction

Yang W., Liu c., Li Z. et al.

Brain and Behavior, 2025
Assessing Causality Between Plasma Brain‐Derived Neurotrophic Factor With Major Depression Disorder: A Bidirectional Mendelian Randomization Study

Chen M., Huang H., Liu Y. et al.

Clinical Kidney Journal, 2025
Cardiometabolic protein expression levels and pathways associated with kidney function decline in older European adults with advanced kidney disease

Aylward R., Hayward S., Chesnaye N. et al.

Pathogens, 2025
The Role of Caspase-1 and Caspase-4 in Modulating Gingival Epithelial Cell Responses to Aggregatibacter actinomycetemcomitans Infection

Demirel K., Neves Guimaraes A., Demirel I.

mBio, 2025
Metagenomic and transcriptomic investigation of pediatric acute liver failure cases reveals a common pathway predominated by monocytes

de Kleine R., Carbo E., Lexmond W. et al.

Biological Procedures Online, 2025
Therapeutic Targets for Gastric Cancer: Mendelian Randomization and Colocalization Analysis

Wang Y., Liu Z., Liu W. et al.

Liver International Communications, 2025
Extracellular Cathepsin B Is a Potential Therapeutic Target in Hepatocellular Carcinoma

van Mourik H., Westheim A., Schneider C. et al.

Clinical Cancer Research, 2025
A Phase I Dose Escalation and Cohort Expansion Study of CB307, a Trispecific Humabody against PSMA, CD137, and Albumin in Patients with PSMA-Positive Solid Tumors

de Bono J., Williams A., Melero I. et al.

Vascular Pharmacology, 2025
PCSK6 ablation in blood circulating cells increases atherosclerotic burden, but improves plaque stability by activating Th17-smooth muscle cell modulatory axis

Suur B., Karadimou G., Willems C. et al.

Journal of Pharmaceutical Analysis, 2025
Prioritization of potential drug targets for diabetic kidney disease using integrative omics data mining and causal inference

Zhang J., Peng J., Yu C. et al.

Nature Communications, 2025
Plasma exchange and radiation resensitize immunotherapy-refractory melanoma: a phase I trial

Orme J., Zhang H., Lingamaneni P. et al.